Representatives recently introduced the Medicare Physician Data-Driven Performance Payment System Act, drawing praise from the House of Medicine. 

Rad Partners said the addition will help support the company's long-term focus on "physician-led excellence, clinical and technology innovation, and high-quality radiology services at scale."

Last month the Department of Health and Human Services asked hospital dieticians to take an eight-point pledge on inpatient nutrition. This week detractors are firing back at this latest slice of the RFK Jr.-led MAHA agenda. 

The FDA first shared a warning about this issue back in April. Now, the agency has shared a critical update. 

Federal authorities said the shift to regional “Strike Force” models has proven successful, with 6,200 defendants prosecuted nationwide. The DOJ said this latest unit will take a special interest in Northern California. 

WakeMed, a three-hospital system in the North Carolina capital region of Raleigh, would become part of Advocate Health, Atrium’s parent company, if the deal goes through. Advocate is one of the largest not-for-profit health systems in the U.S. 

The agency said it is seeking to exclude semaglutide, tirzepatide and liraglutide from the 503B program based on a lack of clinical evidence. Unless there’s a shortage, the pharmaceuticals would be barred from being compounded by third-parties for the purpose of treating diabetes or obesity. The FDA is seeking public comment on the proposal. 

Some Omnipod 5 devices, manufactured by Insulet, are subject to the Class I recall. The products with the defect must be removed from where they are used or sold to ensure safety, as lower-than-expected insulin doses could have potentially lethal repercussions.